Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Kickback Trial
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Game Over, post: 6209787"]<font size="6">Seriously game over. Novartis riding a wave of atrocious possibly criminal conduct, globally, opened pandora's box by not resolving this sooner & subsequently exacerbated by the Cohen revelations that themselves may be under criminal referral. </font></p><p><font size="6"><br /></font></p><p><font size="6">You have to wonder how grossly inept Novartis legal was allowing this festering boil to stretch for nearly a decade, exposing their own clients & exposing all the dirty laundry while paying their big shot law firm potentially 10's of millions. What a waste. Who gets fired?</font></p><p><font size="6"><br /></font></p><p><font size="6">If you're the Govt (& you don't want to fuck with the SDNY the same SDNY that goes after the president) What incentive do you have to settle? US stands to win triple damages. </font></p><p><font size="6"><br /></font></p><p><font size="6">Novartis ultimate argument rests on "everyone was doing it" At a time when they are launching drugs in the 6 figure range & 7 figure price range while Perdue's family & company are facing annihilation for similar marketing</font></p><p><font size="6"><br /></font></p><p><font size="6">Grab your Popcorn folks ! </font></p><p><font size="6"><br /></font></p><p><font size="6"><b><a href="https://www.nytimes.com/2019/04/01/health/sacklers-oxycontin-lawsuits.html" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.nytimes.com/2019/04/01/health/sacklers-oxycontin-lawsuits.html" rel="nofollow">https://www.nytimes.com/2019/04/01/health/sacklers-oxycontin-lawsuits.html</a></b></font></p><p><font size="6"><br /></font></p><p><font size="6"><b>Novartis to face doctor kickback suit, rules a Manhattan District Judge</b></font></p><p><br /></p><p><br /></p><p>APRIL 3, 2019 10:30</p><p>by <a href="https://www.financial-world.org/author/6/sourav-d/" target="_blank" class="externalLink ProxyLink" data-proxy-href="https://www.financial-world.org/author/6/sourav-d/" rel="nofollow">SOURAV D</a> |</p><p><br /></p><p><b>On Monday, the 1st of April 2019, a US Federal Judge had ruled a decision that the Novartis AG, a Swiss multinational pharmaceutical headquartered in Basel, must face a lawsuit over allegations of paying millions of dollars allegedly to doctors to prod them in prescribing Novartis’</b> drugs, adding that the US government had proffered substantial evidence of a “company-wide kickback scheme”.</p><p><br /></p><p>Apart from that, the Manhattan US District<b> Judge, Paul Gardephe had also rejected the third largest Swiss company’s plea to keep key government evidence out of the case, saying that the government would not have to prove any kind of direct “quid pro quo” agreement between doctors and Novartis to hold the company liable.</b></p><p><br /></p><p><b>In fact, the ruling of Manhattan Federal District Judge means that the case would likely to head for trial, unless Novartis agrees to a settlement.</b> Expressing disappointment over Monday’s (April 1st) decision, a Novartis spokesman, Eric Althoff wrote in an emailed response, “We are disappointed in today’s decision and look forward to presenting our case at trial.</p><p><br /></p><p>We continue to believe that the government has insufficient evidence to support its claims”. Nonetheless, origin of the case dated back to early 2011, when a whistleblower, Oswald Bilotta, a former Novartis representative had filed a lawsuit against its former company accusing that the company had been paying millions to doctors to point them to prescribe Novartis drugs, and such kind of lawsuits allow individuals to sue a company on behalf of the government and a government may choose to intervene the case anytime it wishes.[/QUOTE]</p><p><br /></p>
[QUOTE="Game Over, post: 6209787"][SIZE=6]Seriously game over. Novartis riding a wave of atrocious possibly criminal conduct, globally, opened pandora's box by not resolving this sooner & subsequently exacerbated by the Cohen revelations that themselves may be under criminal referral. You have to wonder how grossly inept Novartis legal was allowing this festering boil to stretch for nearly a decade, exposing their own clients & exposing all the dirty laundry while paying their big shot law firm potentially 10's of millions. What a waste. Who gets fired? If you're the Govt (& you don't want to fuck with the SDNY the same SDNY that goes after the president) What incentive do you have to settle? US stands to win triple damages. Novartis ultimate argument rests on "everyone was doing it" At a time when they are launching drugs in the 6 figure range & 7 figure price range while Perdue's family & company are facing annihilation for similar marketing Grab your Popcorn folks ! [B][/B] [B][URL]https://www.nytimes.com/2019/04/01/health/sacklers-oxycontin-lawsuits.html[/URL][/B] [B][/B] [B]Novartis to face doctor kickback suit, rules a Manhattan District Judge[/B][/SIZE] APRIL 3, 2019 10:30 by [URL='https://www.financial-world.org/author/6/sourav-d/']SOURAV D[/URL] | [B]On Monday, the 1st of April 2019, a US Federal Judge had ruled a decision that the Novartis AG, a Swiss multinational pharmaceutical headquartered in Basel, must face a lawsuit over allegations of paying millions of dollars allegedly to doctors to prod them in prescribing Novartis’[/B] drugs, adding that the US government had proffered substantial evidence of a “company-wide kickback scheme”. Apart from that, the Manhattan US District[B] Judge, Paul Gardephe had also rejected the third largest Swiss company’s plea to keep key government evidence out of the case, saying that the government would not have to prove any kind of direct “quid pro quo” agreement between doctors and Novartis to hold the company liable.[/B] [B]In fact, the ruling of Manhattan Federal District Judge means that the case would likely to head for trial, unless Novartis agrees to a settlement.[/B] Expressing disappointment over Monday’s (April 1st) decision, a Novartis spokesman, Eric Althoff wrote in an emailed response, “We are disappointed in today’s decision and look forward to presenting our case at trial. We continue to believe that the government has insufficient evidence to support its claims”. Nonetheless, origin of the case dated back to early 2011, when a whistleblower, Oswald Bilotta, a former Novartis representative had filed a lawsuit against its former company accusing that the company had been paying millions to doctors to point them to prescribe Novartis drugs, and such kind of lawsuits allow individuals to sue a company on behalf of the government and a government may choose to intervene the case anytime it wishes.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Kickback Trial
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Novartis
>
Kickback Trial
>